Integrin inhibitors based on the tripeptide sequence Arg-Gly-Asp (RGD) are potential therapeutics for the treatment of idiopathic pulmonary fibrosis (IPF). Herein, we describe an expeditious three-step synthetic sequence of Horner–Wadsworth–Emmons olefination, diimide reduction and global deprotection to synthesise cores for these compounds in high yields (63–83% over 3 steps) with no need for chromatography. Key to this transformation is the phosphoramidate protecting group, which is stable to metalation steps.
Keywords: Arginine; Horner–Wadsworth–Emmons; Integrin; Phosphoramidate; Tetrahydronaphthyridine
|Format: DOCX||Size: 2.5 MB||Download|
When a peer-reviewed version of this preprint is available in the Beilstein Journals, this information will be updated in the information box above. If no peer-reviewed version is available, please cite this preprint using the following information:
Lippa, R. A.; Murphy, J. A.; Barrett, T. Beilstein Arch. 2020, 202055. doi:10.3762/bxiv.2020.55.v1
|Download RIS (Reference Manager)||Download BIB (BIBTEX)|